Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237701 · ClinicalTrials.gov registry record
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
A clinical trial of Heart Failure and Heart Failure With Preserved Ejection Fraction, sponsored by Yale University.
- Recruiting
- Registry status
- 40,000
- Enrollment target
- 1
- Study location
NCT04237701: Recruiting study of Heart Failure and Heart Failure With Preserved Ejection Fraction, sponsored by Yale University.
NCT04237701 is a study of Heart Failure and Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Yale University. The registered enrollment target is 40,000 participants, above the 1,948-participant average among 397 other Heart Failure trials with a reported enrollment target (1953% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04237701, a study of Heart Failure and Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 40,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System.
Primary Outcome
Heart Failure hospitalizations
Conditions Studied
Study Locations (1)
Connecticut
- Yale New Haven Health System - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,000 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2030-12-30 |
What NCT04237701 shows while recruiting
NCT04237701 is an observational study that tracks outcomes without assigning an intervention. Its 40,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,948-participant average among 397 other Heart Failure trials with a reported enrollment target (1953% higher).
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT04237701 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04237701 about?
NCT04237701 is a clinical study titled "Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System". The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System.
What is the current status of trial NCT04237701?
This trial is currently recruiting. The enrollment target is 40,000 participants. The study started on 2019-10-01. Estimated completion is 2030-12-30.
What conditions does trial NCT04237701 study?
This clinical trial studies the following conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class IV.
Who is sponsoring clinical trial NCT04237701?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04237701 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04237701's enrollment target sits among peer trials
40,000 5th of 397 higher than 393 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI